期刊文献+

口服转鲑鱼降钙素基因酵母的安全性评价

Safety Evaluation of Recombinant Sacchromyces cerevisiae Expressing Salmon Calcitonin by Orally Administration
原文传递
导出
摘要 以小鼠为实验对象对表达鲑鱼降钙素的转基因酵母进行了毒理学实验,包括急性毒性实验、遗传毒性实验(小鼠骨髓微核实验、小鼠精子畸形实验)、传统致畸实验和大鼠30 d喂养实验.结果表明,急性毒性实验显示LD50>10.0 g/kg,属于实际无毒物质;遗传毒性实验结果均为阴性,显示无致突变性;致畸实验结果表明转鲑鱼降钙素基因酵母对小鼠不会产生母体毒性,对小鼠胚胎发育无影响且无致畸作用;30 d喂养实验中各项检测指标均无显著差异(p>0.05),组织病理切片检查未发现病理性变化.本文的结论是口服转鲑鱼降钙素基因酵母未对实验动物造成不良影响,是安全无毒的. To evaluate the toxicological safety of recombinant Sacchromyces cerevisiae expressing salmon calcitonin, tests included acute toxicity test, micronucleus test, sperm shape abnormality test, traditional teratogenicity test and 30 days feeding test were performed. Results showed oral LD50 was higher than 10.0 g/kg both in male and female mice. Micronucleus test and Sperm shape abnormality test were negative. There was no maternal toxicity or embryotoxicity in teratogeniccity test. No significant toxicity was detected in 30 days feeding test. Conclusion could be drawn that recombinant Saccharomyces cerevisiae expressing salmon calcitonin has no negative influences on the animal, which proves that it is safe and nontoxic.
出处 《武汉大学学报(理学版)》 CAS CSCD 北大核心 2009年第5期577-586,共10页 Journal of Wuhan University:Natural Science Edition
基金 国家高技术研究发展计划(863)项目(819-04-10)
关键词 鲑鱼降钙素 酿酒酵母 遗传毒性 安全性 salmon calcitonin saccharomyces cerevisiae genotoxicity safety
  • 相关文献

参考文献16

  • 1Kraenzlin M E, Seibel M J, Trechsel U, et al. The Effect of Intranasal Salmon Calcitonin on Postmenopausal Bone Turnover as Assessed by Biochemical Markers:Evidenee of Maximal Effect after 8 Weeks of Continuous Treatment [J]. CalcifTissue Int, 1996, ( 58 ) : 216-220.
  • 2Maclntyre I, Parsons J A, Robinson C J. The Effect of Thyrocalcitonin on Blood Bone Calcium Equilibrium in the Perfused Tibiate of the Cat[J]. J Physiol, 1967,191 : 393-405.
  • 3Austin L A. Hunter H. Calcitonin Physiology and Pathophysiology[J].N Engl J Med , 1981,304 (5) : 269 -276.
  • 4Yang M, Velaga S, Yamamoto H,etal. Characterisation of Salmon Caleitonin in Spray-Dried Powder for Inhalation Effect of Chitosan[J].International Journal of Pharmaceutics ,2007,331 :176-181.
  • 5Yu S Y, Ju Y J, Seung H O,et al. Improved Intestinal Delivery of Salmon Calcitonin by Lys18-A-Mine Specific Pegylation:Stability, Permeability, Pharmacokinetic Behavior and in vivo Hypo-Calcemic Efficacy [J]. Journal of Controlled Release, 2006, 114: 334- 342.
  • 6Blanquet S, Marol-Bonnin S, Beyssac E, et al. The Biodrug Concept: An Innovative Approach to Therapy [J]. Trends Biotechnol,2001,19(10) :393-400.
  • 7Blanquet S, Antonelli R, Laforet L,et al. Living Recombinant Saccharomyces cerevisiae Secreting Proteins or Peptides as a New Drug Delivery in the Gut[J]. Biotechnol, 2004,110 : 37-49.
  • 8Sun Pingnan, Zhang Xuecheng, Zang Xiaonan, et al. Anti-Hyperealcemic Effect of Orally Administered Recombinant Saccharomyces Cerevisiae Expressing Salmon Calcitonin on Hypercalcemie Rats[J].Biotechnol Lett ,2007,29(7) : 1013-1018.
  • 9Petes T D, Botstein D. Simple Mendelian Inheritance of the Reiterated Ribosomaldna of Yeast[J].Pro Natl Acad Sci USA ,1977,74:5091-5095.
  • 10王玉梅,张学成,周一江,隋正红,茅云翔.cpcB与CT融合蛋白表达质粒在大肠杆菌中的表达和纯化[J].高技术通讯,2005,15(5):62-66. 被引量:4

二级参考文献40

  • 1吕锌锌,刘少杰,刘杰,李干佐,郑利强.微乳液作为药物载体研究进展[J].化学通报,2004,67(7):551-551. 被引量:8
  • 2陈华兵,翁婷,杨祥良.微乳在现代药剂学中的研究进展[J].中国医药工业杂志,2004,35(8):502-506. 被引量:23
  • 3孟迅吾,周学瀛.骨质疏松症的诊断、预防和治疗[J].中华内分泌代谢杂志,1993,9(4):246-248. 被引量:12
  • 4Vandamme TF.Microemulsions as ocular drug delivery systems:recent developments and future challenges[J].Progress in Retinal Eye Reaseach,2002,21(1):15-34.
  • 5Kawakami K,Yoshikawa T,Moroto Y,et al.Moicroemulsion formulation for enhanced absorption of poorly soluble drug ⅠPrescription design[J].J Controlled Release,2002,81(1-2):65-74.
  • 6Shen WC.Oral peptide and protein delivery:unfulfilled promises?[J].Drug Discovery Today,2003,8(14):607-608.
  • 7Gao ZG,Choi HG,Shin HJ,et al.Physicochemical characterization and evaluation of a microemulsion system for oral delivery of Cyclosporin A[J].Int J Pharm,1998,161(1):75-86.
  • 8Ritschel WA.Microemulsions for improved peptide absorption from the gastrointestinal tract[J].Methods Find Exp Clin Pharmacol,1991,13(3):205-220.
  • 9高申.现代药物新剂型新技术[M].北京:人民军医出版社,2003.166-171.
  • 10Vermette P,Meagher L,Gagnon E,et al.Immobilized liposome layers for drug delivery applications:inhibition of angiogenesis[J].J Controlled Release,2002,80(1-3):179-195.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部